Skip to main content
. 2016 Sep;7(9-10):301–308. doi: 10.18632/genesandcancer.121

Figure 2. Progression-free survival comparison between the experimental treatment (ePFS; grey) according to molecular profiling and the prior therapy (PFS; black) of the first 19 patients treated within the ONCO-T-PROFILE project.

Figure 2